Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for many people with Type 1 diabetes. Little attention has been paid to how individuals self-treat hypoglycaemia and their likes and dislikes of clinically recommended treatments. We explored participants' experiences of self-treating hypoglycaemia after attending a structured education programme for people with Type 1 diabetes. Our aims were: to identify treatments that are acceptable to people with Type 1 diabetes; and to provide recommendations for promoting self-treatment in line with clinical guidelines. Methods: Thirty adults with Type 1 diabetes were recruited from the Dose Adjustment for Normal Eating (DAFNE) programme in the UK. Study ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...
Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Hegney, DG ORCiD: 0000-0003-1267-1760BACKGROUND: Hypoglycaemia, a common complication of diabetes dr...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...
Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Hegney, DG ORCiD: 0000-0003-1267-1760BACKGROUND: Hypoglycaemia, a common complication of diabetes dr...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...